Source document or public record

FDA 510(k) K193519 — BioFire Blood Culture Identification 2 (BCID2) Panel

FDA 510(k) index record K193519. Device: BioFire Blood Culture Identification 2 (BCID2) Panel. Applicant as listed: Biofire Diagnostics, LLC. Decision date: 2020-03-18.

OtherU.S. Food and Drug Administration (FDA)2020-03-18

Source

"device_name": "BioFire Blood Culture Identification 2 (BCID2) Panel"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K193519.

Device name: BioFire Blood Culture Identification 2 (BCID2) Panel. Applicant as listed: Biofire Diagnostics, LLC.

Decision date: 2020-03-18. Decision wording: Substantially Equivalent.

Product code: PEN. Regulation: 21 CFR 866.3365. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.